Daxor Corporation Announces Launch of BVA Program at Mid-South Largest Integrated Network

Community Hospital Purchases BVA Analyzer With Focus on Improving Outpatient Heart Failure Care

Oak Ridge, TN, Aug. 29, 2024 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology, announces the expansion of its blood volume analysis (BVA) technology through the acquisition of the BVA analyzer. This advancement not only enhances revenue streams, but also sets the stage for projected accelerated sales growth for the rest of the year.

Read more at globenewswire.com